These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5141610)

  • 1. [Antiviral inhibitors and antibodies in the serum of subjects vaccinated against influenza].
    Kazakova VN; Kupriashina LM
    Vopr Virusol; 1971; 16(6):651-5. PubMed ID: 5141610
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
    Gwaltney JM; Edmondson WP; Rothenberg R; White PW
    Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
    [No Abstract]   [Full Text] [Related]  

  • 3. Field trial with human and equine influenza vaccines in children: protection and antibody titres.
    Wesselius-de Casparis A; Masurel N; Kerrebijn KF
    Bull World Health Organ; 1972; 46(2):151-7. PubMed ID: 4555773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge.
    Edmondson WP; Rothenberg R; White PW; Gwaltney JM
    Am J Epidemiol; 1971 Jun; 93(6):480-6. PubMed ID: 5562720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vaccination of children against influenza].
    Pressler K; Sattler HJ; Schöck V
    Z Kinderheilkd; 1975; 118(4):265-9. PubMed ID: 1130119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Persistence of anti-V hemagglutination-inhibiting antibodies and complement-fixing antibodies induced by administration of inactivated influenza vaccines].
    Profeta ML
    Ann Sclavo; 1972; 14(2):145-58. PubMed ID: 4669354
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antibody response after anti-influenza vaccination in a closed community and protective effect against the disease].
    Scalise G; Maida A; Mura MS; Pettinato S; Mura M
    Ann Sclavo; 1974; 16(3):243-60. PubMed ID: 4429406
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines].
    Profeta ML; Zanetti A; Bergamini F
    Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136
    [No Abstract]   [Full Text] [Related]  

  • 9. Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization.
    Foy HM; Cooney MK; McMahan R; Bor E; Grayston JT
    JAMA; 1971 Aug; 217(8):1067-71. PubMed ID: 5109428
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccination against Hong Kong influenza in Britain, 1968-9. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Tyrrell DA; Buckland R; Rubenstein D; Sharpe DM
    J Hyg (Lond); 1970 Sep; 68(3):359-68. PubMed ID: 4917914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sero-epidemiological investigations of the effectiveness of influenza vaccine with attenuated live viruses of types A2 and B].
    Ivan A; Vancea G; Zvorişteanu V; Oană C; Rusu F; Gherman A; Meleghi M
    Stud Cercet Inframicrobiol; 1968; 19(5):355-61. PubMed ID: 5716054
    [No Abstract]   [Full Text] [Related]  

  • 12. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses.
    Sugiura A; Yanagawa H; Enomoto C; Ueda M; Tobita K
    J Infect Dis; 1970 Dec; 122(6):472-8. PubMed ID: 5496135
    [No Abstract]   [Full Text] [Related]  

  • 13. Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines.
    Beare AS; Tyrrell DA; Hobson D; Howells CH; Pereira MS; Pollock TM; Tyler LE
    J Hyg (Lond); 1969 Mar; 67(1):1-11. PubMed ID: 5278156
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antigenicity of various influenza vaccines in man].
    Kuwert E; Höhner PG; Bertrams J; Schriever O
    Dtsch Med Wochenschr; 1971 May; 96(22):938-45. PubMed ID: 4325348
    [No Abstract]   [Full Text] [Related]  

  • 15. [Persistence of antibodies inhibiting hemagglutination by influenza viruses in aged vaccinated women. Changes in antibody titer after re-vaccination].
    Visconti M; Verde F; Frezza G; Russo V
    Boll Soc Ital Biol Sper; 1973 Feb; 49(4):173-7. PubMed ID: 4779760
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of the avidity of anti-influenza antibodies in sera of convalescents or subjects vaccinated with a live influenza virus vaccine.
    Kallas EV; Aleksandrova GI; Smorodintsev AA
    Acta Virol; 1969 Nov; 13(6):489-98. PubMed ID: 4391716
    [No Abstract]   [Full Text] [Related]  

  • 17. [Research on the immunity against influenza in the population of Milan in the fall of 1972. Distribution of h.i.a. (hemagglutination inhibition antibodies) against A-Hong Kong-68 and A-England-42-72 viruses and the immunizing effectiveness of current vaccines].
    Profeta ML; Bergamini F
    Boll Ist Sieroter Milan; 1973; 52(1):25-31. PubMed ID: 4714450
    [No Abstract]   [Full Text] [Related]  

  • 18. [Research on influenza vaccination with A2 + B vaccine].
    Bellelli E; Nardi G; Bracchi U; Tanzi ML; Monaci V; Sansebastiano G
    Ann Sclavo; 1971; 13(5):584-96. PubMed ID: 5153401
    [No Abstract]   [Full Text] [Related]  

  • 19. Cigarette smoking and hemagglutination inhibition response to influenza after natural disease and immunization.
    Finklea JF; Hasselblad V; Riggan WB; Nelson WC; Hammer DI; Newill VA
    Am Rev Respir Dis; 1971 Sep; 104(3):368-76. PubMed ID: 5098670
    [No Abstract]   [Full Text] [Related]  

  • 20. [Follow-up of epidemiological and serological indices in groups of subjects vaccinated against influenza].
    Topciu V; Dioşi P; Voicoulesco D; Crişan M; Moldovan E; Muţiu D; Brizu N; Dăianu E; Nevinglovschi O
    Arch Roum Pathol Exp Microbiol; 1965 Jun; 24(2):489-500. PubMed ID: 5877536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.